Report Detail
Global (United States, European Union and China) G-CSF and G-CSF Biosimilars Market Research Report 2019-2025
- RnM3669267 |
- 14 August, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
G-CSF, which is also known as filgrastim, is a growth factor used to aid the recovery of bone marrow after chemotherapy treatment for cancer, especially in patients with neutropenia (low white blood cell count in the blood), which causes reduced resistance to infections. It can also be used to stimulate mobilization of haematopoietic stem cells for collection and transplantation.
In 2019, the market size of G-CSF and G-CSF Biosimilars is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for G-CSF and G-CSF Biosimilars.
This report studies the global market size of G-CSF and G-CSF Biosimilars, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the G-CSF and G-CSF Biosimilars sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Pfizer
Novartis
Roche
Merck & Co.
Sanofi
Johnson & Johnson
Gilead Science
GlaxoSmithKline
AbbVie
Amgen
AstraZeneca
Bayer
Market Segment by Product Type
Blood Disorders
Oncology Diseases
Chronic And Autoimmune Diseases
Growth Hormone Deficiencies
Market Segment by Application
Human Growth Hormone
Erythropoietin
Monoclonal Antibodies
Insulin
Interferon
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the G-CSF and G-CSF Biosimilars status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key G-CSF and G-CSF Biosimilars manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of G-CSF and G-CSF Biosimilars are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global G-CSF and G-CSF Biosimilars Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Blood Disorders
- 1.3.3 Oncology Diseases
- 1.3.4 Chronic And Autoimmune Diseases
- 1.3.5 Growth Hormone Deficiencies
- 1.4 Market Segment by Application
- 1.4.1 Global G-CSF and G-CSF Biosimilars Market Share by Application (2019-2025)
- 1.4.2 Human Growth Hormone
- 1.4.3 Erythropoietin
- 1.4.4 Monoclonal Antibodies
- 1.4.5 Insulin
- 1.4.6 Interferon
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global G-CSF and G-CSF Biosimilars Market Size
- 2.1.1 Global G-CSF and G-CSF Biosimilars Revenue 2014-2025
- 2.1.2 Global G-CSF and G-CSF Biosimilars Sales 2014-2025
- 2.2 G-CSF and G-CSF Biosimilars Growth Rate by Regions
- 2.2.1 Global G-CSF and G-CSF Biosimilars Sales by Regions 2014-2019
- 2.2.2 Global G-CSF and G-CSF Biosimilars Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 G-CSF and G-CSF Biosimilars Sales by Manufacturers
- 3.1.1 G-CSF and G-CSF Biosimilars Sales by Manufacturers 2014-2019
- 3.1.2 G-CSF and G-CSF Biosimilars Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 G-CSF and G-CSF Biosimilars Revenue by Manufacturers (2014-2019)
- 3.2.2 G-CSF and G-CSF Biosimilars Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global G-CSF and G-CSF Biosimilars Market Concentration Ratio (CR5 and HHI)
- 3.3 G-CSF and G-CSF Biosimilars Price by Manufacturers
- 3.4 Key Manufacturers G-CSF and G-CSF Biosimilars Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into G-CSF and G-CSF Biosimilars Market
- 3.6 Key Manufacturers G-CSF and G-CSF Biosimilars Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Blood Disorders Sales and Revenue (2014-2019)
- 4.1.2 Oncology Diseases Sales and Revenue (2014-2019)
- 4.1.3 Chronic And Autoimmune Diseases Sales and Revenue (2014-2019)
- 4.1.4 Growth Hormone Deficiencies Sales and Revenue (2014-2019)
- 4.2 Global G-CSF and G-CSF Biosimilars Sales Market Share by Type
- 4.3 Global G-CSF and G-CSF Biosimilars Revenue Market Share by Type
- 4.4 G-CSF and G-CSF Biosimilars Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global G-CSF and G-CSF Biosimilars Sales by Application
6 United States
- 6.1 United States G-CSF and G-CSF Biosimilars Breakdown Data by Company
- 6.2 United States G-CSF and G-CSF Biosimilars Breakdown Data by Type
- 6.3 United States G-CSF and G-CSF Biosimilars Breakdown Data by Application
7 European Union
- 7.1 European Union G-CSF and G-CSF Biosimilars Breakdown Data by Company
- 7.2 European Union G-CSF and G-CSF Biosimilars Breakdown Data by Type
- 7.3 European Union G-CSF and G-CSF Biosimilars Breakdown Data by Application
8 China
- 8.1 China G-CSF and G-CSF Biosimilars Breakdown Data by Company
- 8.2 China G-CSF and G-CSF Biosimilars Breakdown Data by Type
- 8.3 China G-CSF and G-CSF Biosimilars Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World G-CSF and G-CSF Biosimilars Breakdown Data by Company
- 9.2 Rest of World G-CSF and G-CSF Biosimilars Breakdown Data by Type
- 9.3 Rest of World G-CSF and G-CSF Biosimilars Breakdown Data by Application
- 9.4 Rest of World G-CSF and G-CSF Biosimilars Breakdown Data by Countries
- 9.4.1 Rest of World G-CSF and G-CSF Biosimilars Sales by Countries
- 9.4.2 Rest of World G-CSF and G-CSF Biosimilars Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Pfizer
- 10.1.1 Pfizer Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of G-CSF and G-CSF Biosimilars
- 10.1.4 G-CSF and G-CSF Biosimilars Product Introduction
- 10.1.5 Pfizer Recent Development
- 10.2 Novartis
- 10.2.1 Novartis Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of G-CSF and G-CSF Biosimilars
- 10.2.4 G-CSF and G-CSF Biosimilars Product Introduction
- 10.2.5 Novartis Recent Development
- 10.3 Roche
- 10.3.1 Roche Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of G-CSF and G-CSF Biosimilars
- 10.3.4 G-CSF and G-CSF Biosimilars Product Introduction
- 10.3.5 Roche Recent Development
- 10.4 Merck & Co.
- 10.4.1 Merck & Co. Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of G-CSF and G-CSF Biosimilars
- 10.4.4 G-CSF and G-CSF Biosimilars Product Introduction
- 10.4.5 Merck & Co. Recent Development
- 10.5 Sanofi
- 10.5.1 Sanofi Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of G-CSF and G-CSF Biosimilars
- 10.5.4 G-CSF and G-CSF Biosimilars Product Introduction
- 10.5.5 Sanofi Recent Development
- 10.6 Johnson & Johnson
- 10.6.1 Johnson & Johnson Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of G-CSF and G-CSF Biosimilars
- 10.6.4 G-CSF and G-CSF Biosimilars Product Introduction
- 10.6.5 Johnson & Johnson Recent Development
- 10.7 Gilead Science
- 10.7.1 Gilead Science Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of G-CSF and G-CSF Biosimilars
- 10.7.4 G-CSF and G-CSF Biosimilars Product Introduction
- 10.7.5 Gilead Science Recent Development
- 10.8 GlaxoSmithKline
- 10.8.1 GlaxoSmithKline Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of G-CSF and G-CSF Biosimilars
- 10.8.4 G-CSF and G-CSF Biosimilars Product Introduction
- 10.8.5 GlaxoSmithKline Recent Development
- 10.9 AbbVie
- 10.9.1 AbbVie Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of G-CSF and G-CSF Biosimilars
- 10.9.4 G-CSF and G-CSF Biosimilars Product Introduction
- 10.9.5 AbbVie Recent Development
- 10.10 Amgen
- 10.10.1 Amgen Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of G-CSF and G-CSF Biosimilars
- 10.10.4 G-CSF and G-CSF Biosimilars Product Introduction
- 10.10.5 Amgen Recent Development
- 10.11 AstraZeneca
- 10.12 Bayer
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 G-CSF and G-CSF Biosimilars Sales Channels
- 11.2.2 G-CSF and G-CSF Biosimilars Distributors
- 11.3 G-CSF and G-CSF Biosimilars Customers
12 Market Forecast
- 12.1 Global G-CSF and G-CSF Biosimilars Sales and Revenue Forecast 2019-2025
- 12.2 Global G-CSF and G-CSF Biosimilars Sales Forecast by Type
- 12.3 Global G-CSF and G-CSF Biosimilars Sales Forecast by Application
- 12.4 G-CSF and G-CSF Biosimilars Forecast by Regions
- 12.4.1 Global G-CSF and G-CSF Biosimilars Sales Forecast by Regions 2019-2025
- 12.4.2 Global G-CSF and G-CSF Biosimilars Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on G-CSF and G-CSF Biosimilars. Industry analysis & Market Report on G-CSF and G-CSF Biosimilars is a syndicated market report, published as Global (United States, European Union and China) G-CSF and G-CSF Biosimilars Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of G-CSF and G-CSF Biosimilars market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
